Rapid antibody medium
Taiwan·Risk Class 1·CSL LIMITED·Registered Oct 29, 2010 – Oct 29, 2015Cancelled- Analysis ID
- b4866e1ebf95a8b576f765e6bcd5e8fe
- Customs Code
- DHA04400943001
- Manufacturer
- CSL LIMITED
- Manufacturer Country
- Australia
- Authorized Representative
- GIRAFFES PHARMACEUTICAL COMPANY LTD.
- Intended Use
- Limited to the first level identification range of intensive medium (B.9600) for in vitro diagnosis of medical device management methods.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.9600 Intensive medium for in vitro diagnostics
- Import Information
- import
- Registration Date
- Oct 29, 2010
- Expiry Date
- Oct 29, 2015
- Cancellation Date
- Apr 25, 2018
- Status
- Logged out
- Reason
- 自行鍵入
Top companies providing products similar to "Rapid antibody medium"
Recently registered similar products
Access comprehensive regulatory information for Rapid antibody medium in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number b4866e1ebf95a8b576f765e6bcd5e8fe and manufactured by CSL LIMITED. The authorized representative in Taiwan is GIRAFFES PHARMACEUTICAL COMPANY LTD..
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including IMMULAB PTY LTD, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.